CervoMed Inc (CRVO)
25.05
+0.99
(+4.11%)
USD |
NASDAQ |
May 06, 13:07
CervoMed Free Cash Flow: -7.450M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.450M |
| September 30, 2023 | -8.385M |
| June 30, 2023 | -13.85M |
| March 31, 2023 | -15.21M |
| December 31, 2022 | -14.97M |
| September 30, 2022 | -14.52M |
| June 30, 2022 | -14.74M |
| March 31, 2022 | -14.06M |
| December 31, 2021 | -14.50M |
| September 30, 2021 | -14.87M |
| June 30, 2021 | -15.41M |
| March 31, 2021 | -15.22M |
| December 31, 2020 | -13.55M |
| September 30, 2020 | -12.60M |
| June 30, 2020 | -11.24M |
| March 31, 2020 | -10.71M |
| December 31, 2019 | -9.858M |
| September 30, 2019 | -10.45M |
| June 30, 2019 | -10.21M |
| March 31, 2019 | -10.14M |
| December 31, 2018 | -10.77M |
| September 30, 2018 | -10.03M |
| June 30, 2018 | -12.00M |
| March 31, 2018 | -12.21M |
| December 31, 2017 | -12.78M |
| Date | Value |
|---|---|
| September 30, 2017 | -11.90M |
| June 30, 2017 | -9.505M |
| March 31, 2017 | -9.561M |
| December 31, 2016 | -10.77M |
| September 30, 2016 | -11.93M |
| June 30, 2016 | -11.96M |
| March 31, 2016 | -11.59M |
| December 31, 2015 | -9.628M |
| September 30, 2015 | -8.984M |
| June 30, 2015 | -9.070M |
| March 31, 2015 | -11.27M |
| December 31, 2014 | -9.030M |
| September 30, 2014 | -7.101M |
| June 30, 2014 | -5.455M |
| March 31, 2014 | -1.217M |
| December 31, 2013 | -1.185M |
| September 30, 2013 | -2.682M |
| June 30, 2013 | -2.908M |
| March 31, 2013 | -2.865M |
| December 31, 2012 | -4.310M |
| September 30, 2012 | -6.030M |
| June 30, 2012 | -9.972M |
| March 31, 2012 | -13.42M |
| December 31, 2011 | -12.15M |
| September 30, 2011 | -9.334M |
Free Cash Flow Range, Past 5 Years
-15.41M
Minimum
Jun 2021
-7.450M
Maximum
Dec 2023
-12.73M
Average
-13.85M
Median
Jun 2023
Free Cash Flow Benchmarks
| GlucoTrack Inc | -6.558M |
| Regen BioPharma Inc | -0.4821M |
| AIM ImmunoTech Inc | -21.85M |
| Protalix BioTherapeutics Inc | -2.467M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.538M |
| Cash from Financing (Quarterly) | -0.0934M |
| Free Cash Flow Per Share (Quarterly) | -0.4473 |
| Free Cash Flow Yield | -9.78% |